Agglutinogen I of Bordetella pertussis strain 353/Z (serotype 1) was separated from protective antigen and histamine-sensitizing factor by starch-block electrophoresis. Most of the agglutinogen migrated towards the cathode in starch-block electrophoresis, although some remained near the origin. Fractions containing most of the agglutinogen I were free of detectable mouse-protecting or histamine-sensitizing activities. Agglutinogen 1 from a serotype 1,3 B. pertussis strain (J20) migrated similarly to the agglutinogen I from strain 353/Z. All agglutinogen 3 activity was found at the point of application in the starch block. No clear relationship was found between agglutinogen I and mouse-protecting antigen or histamine-sensitizing factor. Eight different agglutinogens have been described for Bordetella pertussis (1, 5, 6). Six of these (1, 2, 3, 4, 5, 6) are species specific, and two (7, 13) are shared with other species of the genus Bordetella. Agglutinogen 1 is common to all strains of B. pertussis, whereas agglutinogens 2, 3, 4, 5, and 6 are found in various combinations as strain-specific antigens. Agglutinogens 2, 3, and 5 resist 100 C for 2.5 hr, but 1, 6, and 7 are destroyed by this treatment (4). The relationship of these agglutinogens to immunity induced by pertussis vaccines is not clear. Work with purified fractions of B. pertussis has indicated that at least some of the agglutinogens are separated from the antigen that is responsible for immunity in the mouse protection test of Kendrick et al. (10). Moreover, no difference in mouse-protective activity has been demonstrated among vaccines prepared from cultures possessing different combinations of agglutinogens (2, 7, 8, 24). These observations indicate that the specific agglutinogens 2, 3, 4, 5, and 6 do not play a significant role in active immunization of mice. This cannot be said with certainty of agglutinogen 1, because this antigen is present in all smooth strains of B. pertussis (5), and definite separation of this agglutinogen and mouse-protective antigen (PA) has not been reported. Recent epidemiological findings (3, 17) and results of passive mouse protection tests (18,